Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2

NCT00218010 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2017-01-12

No results posted yet for this study

Summary

Methadone is a drug that offers significant therapeutic benefits to opiate dependent women who are pregnant. Currently, it is the treatment of choice for this group of people. The purpose of this study is to determine the amount of methadone in the breast milk of women who are breastfeeding and taking methadone for opiate addiction. In addition, this study will evaluate the effects of methadone on infant neurobehavior.

Conditions

  • Breast Feeding
  • Opioid-Related Disorders

Sponsors & Collaborators

Principal Investigators

  • Lauren M. Jansson, MD · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-11-30
Primary Completion
2005-08-31
Completion
2005-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00218010 on ClinicalTrials.gov